Longitudinal assessment of FLT3‐ITD mutated AML patients [29, 64, 65] as well as single‐cell sequencing studies [59, 60] suggests that discrete FLT3‐ITDs are indicative of separate cell populations derived from multiple individual cells that independently acquired FLT3‐ITD mutations. This evidence concerns the gene FLT3 and acute myeloid leukemia.